Eton Pharmaceuticals (NASDAQ:ETON) Now Covered by Analysts at B. Riley

B. Riley initiated coverage on shares of Eton Pharmaceuticals (NASDAQ:ETON – Free Report) in a report released on Friday morning, Marketbeat reports. The firm issued a buy rating and a $21.00 target price on the stock. Several other brokerages have also recently issued reports on ETON. HC Wainwright lifted their price objective on Eton Pharmaceuticals […]

Leave a Reply

Your email address will not be published.

Previous post Klondike Silver (CVE:KS) Trading Down 33.3% – Time to Sell?
Next post Alphabet (NASDAQ:GOOGL) Given New $225.00 Price Target at KeyCorp